The pharmacology and clinical outcomes of amphetamines to treat ADHD: does composition matter?

@article{Hodgkins2012ThePA,
  title={The pharmacology and clinical outcomes of amphetamines to treat ADHD: does composition matter?},
  author={Paul S. Hodgkins and Monica Shaw and Suzanne McCarthy and Floyd R. Sallee},
  journal={CNS drugs},
  year={2012},
  volume={26 3},
  pages={
          245-68
        }
}
Attention-deficit hyperactivity disorder (ADHD) treatment options include pharmacological and nonpharmacological approaches. In North America, psychostimulants (amphetamine and methylphenidate) are considered first-line pharmacological treatments for patients (children, adolescents and adults) with ADHD. However, in the UK, National Institute for Health and Clinical Excellence (NICE) guidelines have placed short-acting d-amphetamine as a third-line treatment option due to a lack of contemporary… CONTINUE READING
BETA

Citations

Publications citing this paper.
SHOWING 1-10 OF 18 CITATIONS

References

Publications referenced by this paper.
SHOWING 1-10 OF 98 REFERENCES

The behavior of children receiving benzedrine

  • C. Bradley
  • Am J Psychiatry
  • 1937
Highly Influential
25 Excerpts

Similar Papers

Loading similar papers…